DIPHENHYDRAMINE

DIPHENHYDRAMINE was reported 166662 times

DIPHENHYDRAMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 146 0.4818
1 GRIP STRENGTH 77 0.3362
2 CENTRAL NERVOUS SYSTEM LUPUS 55 0.2466
3 ADMINISTRATION SITE SWELLING 61 0.1877
4 BLOOD PRESSURE DIASTOLIC ABNORMAL 458 0.1799
5 TEMPERATURE REGULATION DISORDER 364 0.1632
6 POSTMORTEM BLOOD DRUG LEVEL INCREASED 57 0.1528
7 BLOOD PRESSURE SYSTOLIC ABNORMAL 361 0.1459
8 INFUSION SITE MASS 158 0.1454
9 EPIDURAL LIPOMATOSIS 49 0.1424
10 INFUSION SITE DISCHARGE 246 0.1402
11 INFUSION SITE URTICARIA 91 0.1358
12 INFUSION SITE BRUISING 280 0.1295
13 INFUSION SITE PRURITUS 380 0.1203
14 PHARYNGEAL PARAESTHESIA 177 0.1115
15 NEUROLOGIC NEGLECT SYNDROME 57 0.1025
16 FEMALE GENITAL TRACT FISTULA 169 0.0989
17 INFUSION SITE RASH 135 0.0983
18 EAR PRURITUS 333 0.0949
19 INFUSION SITE HAEMORRHAGE 312 0.0947
20 INFUSION SITE DISCOMFORT 97 0.0935
21 INFUSION SITE SWELLING 573 0.0910
22 LUPUS VULGARIS 112 0.0889
23 INFUSION SITE EXTRAVASATION 524 0.0841
24 ANTICHOLINERGIC SYNDROME 128 0.0803
25 INFUSION SITE NODULE 75 0.0780
26 PORPHYRIA ACUTE 107 0.0746
27 BLOOD PRESSURE FLUCTUATION 1682 0.0700
28 POOR VENOUS ACCESS 717 0.0692
29 CHRONIC SINUSITIS 258 0.0687
30 FOOD ALLERGY 528 0.0683
31 CAROTID ARTERY THROMBOSIS 58 0.0683
32 DEEP VEIN THROMBOSIS POSTOPERATIVE 132 0.0659
33 INFUSION SITE ERYTHEMA 555 0.0658
34 BLOOD PRESSURE DIASTOLIC DECREASED 474 0.0641
35 INFUSION SITE PAIN 820 0.0636
36 RADICULOPATHY 165 0.0625
37 RETINITIS 108 0.0625
38 INCORRECT DRUG ADMINISTRATION RATE 264 0.0620
39 INFUSION SITE DISCOLOURATION 54 0.0614
40 INFUSION SITE IRRITATION 78 0.0607
41 BUTTERFLY RASH 61 0.0602
42 SINUSITIS BACTERIAL 62 0.0588
43 PROCTITIS 163 0.0581
44 INFUSION SITE WARMTH 68 0.0555
45 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 115 0.0554
46 MULTIPLE ALLERGIES 432 0.0551
47 BLOOD PRESSURE DIASTOLIC INCREASED 254 0.0550
48 BODY TEMPERATURE FLUCTUATION 114 0.0547
49 DISLOCATION OF VERTEBRA 123 0.0539
50 INFUSION RELATED REACTION 3534 0.0533
51 GRANULOMATOSIS WITH POLYANGIITIS 64 0.0530
52 BLOOD PRESSURE SYSTOLIC INCREASED 1030 0.0528
53 FOETAL DEATH 272 0.0524
54 APLASTIC ANAEMIA 270 0.0516
55 SOFT TISSUE DISORDER 57 0.0514
56 DEATH NEONATAL 71 0.0510
57 SUSPECTED SUICIDE 232 0.0495
58 VEIN RUPTURE 81 0.0484
59 DEVICE INFUSION ISSUE 120 0.0483
60 X-RAY ABNORMAL 86 0.0480
61 SUSPECTED OFF LABEL USE 201 0.0444
62 ADMINISTRATION SITE PAIN 51 0.0442
63 ADJUSTMENT DISORDER 56 0.0431
64 ACCIDENTAL DEATH 80 0.0430
65 BODY TEMPERATURE DECREASED 408 0.0414
66 MACULAR DEGENERATION 492 0.0412
67 BURSITIS 490 0.0403
68 SEASONAL ALLERGY 564 0.0398
69 INSURANCE ISSUE 600 0.0392
70 INFUSION SITE REACTION 117 0.0391
71 EAR INFECTION 1040 0.0390
72 DRUG LEVEL BELOW THERAPEUTIC 214 0.0388
73 IMMUNOGLOBULINS DECREASED 53 0.0386
74 PNEUMONIA VIRAL 119 0.0373
75 BONE EROSION 132 0.0373
76 SINUSITIS 3751 0.0366
77 UPPER RESPIRATORY TRACT INFECTION 1654 0.0358
78 COMPLETED SUICIDE 2924 0.0351
79 IMMUNODEFICIENCY 515 0.0345
80 INFUSION SITE INDURATION 51 0.0344
81 SWOLLEN JOINT COUNT INCREASED 109 0.0341
82 COELIAC DISEASE 334 0.0340
83 LUPUS NEPHRITIS 62 0.0331
84 HEART RATE DECREASED 1152 0.0328
85 OXYGEN SATURATION ABNORMAL 93 0.0327
86 HEREDITARY ANGIOEDEMA 351 0.0327
87 WEIGHT FLUCTUATION 332 0.0317
88 ANAL FISSURE 170 0.0317
89 FACET JOINT SYNDROME 103 0.0316
90 HYPERPARATHYROIDISM SECONDARY 79 0.0315
91 INTENTIONAL PRODUCT USE ISSUE 2721 0.0310
92 BODY TEMPERATURE ABNORMAL 57 0.0309
93 EXPOSURE VIA INGESTION 75 0.0297
94 EXPOSURE TO SARS-COV-2 50 0.0294
95 FAECAL CALPROTECTIN INCREASED 93 0.0293
96 RESPIRATORY TRACT INFECTION VIRAL 68 0.0292
97 SUSPECTED COVID-19 96 0.0291
98 DRUG TOLERANCE DECREASED 78 0.0277
99 TOOTH INFECTION 363 0.0275
100 RESPIRATORY TRACT INFECTION 715 0.0274
101 SKIN INFECTION 304 0.0271
102 THROAT IRRITATION 1210 0.0269
103 COMPARTMENT SYNDROME 69 0.0264
104 APHTHOUS ULCER 205 0.0264
105 DRUG LEVEL ABOVE THERAPEUTIC 121 0.0264
106 RESPIRATORY RATE INCREASED 234 0.0263
107 OBSTRUCTION 105 0.0263
108 ORAL PRURITUS 60 0.0261
109 PERIPHERAL VENOUS DISEASE 104 0.0254
110 JUVENILE IDIOPATHIC ARTHRITIS 62 0.0253
111 NEPHROGENIC ANAEMIA 117 0.0252
112 PHARYNGITIS STREPTOCOCCAL 273 0.0252
113 CYTOKINE RELEASE SYNDROME 504 0.0251
114 RED BLOOD CELL SEDIMENTATION RATE INCREASED 271 0.0245
115 C-REACTIVE PROTEIN ABNORMAL 157 0.0245
116 RHEUMATIC FEVER 109 0.0244
117 BLOOD IMMUNOGLOBULIN G DECREASED 60 0.0242
118 HEART RATE IRREGULAR 547 0.0242
119 DRUG SPECIFIC ANTIBODY PRESENT 156 0.0240
120 CATHETER SITE PAIN 62 0.0239
121 DERMATITIS CONTACT 271 0.0237
122 WOUND INFECTION 257 0.0234
123 PRESCRIBED OVERDOSE 449 0.0232
124 PARAESTHESIA ORAL 331 0.0229
125 TOXICITY TO VARIOUS AGENTS 3823 0.0226
126 OXYGEN SATURATION DECREASED 1274 0.0226
127 MATERNAL EXPOSURE TIMING UNSPECIFIED 85 0.0226
128 DRUG ABUSE 1867 0.0224
129 EYE INFECTION 253 0.0224
130 SKIN ABRASION 105 0.0222
131 PERSONALITY DISORDER 58 0.0221
132 FEBRILE NEUTROPENIA 1467 0.0221
133 ERYTHEMA NODOSUM 77 0.0219
134 GASTROENTERITIS VIRAL 396 0.0219
135 ORAL CANDIDIASIS 287 0.0218
136 WALKING AID USER 143 0.0217
137 AUTOIMMUNE DISORDER 210 0.0215
138 PHARYNGITIS 267 0.0215
139 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 154 0.0215
140 LIMB MASS 47 0.0214
141 BRONCHITIS 1550 0.0209
142 GASTRIC INFECTION 80 0.0209
143 HELICOBACTER INFECTION 214 0.0208
144 BODY TEMPERATURE INCREASED 423 0.0207
145 RED CELL DISTRIBUTION WIDTH INCREASED 86 0.0207
146 CARDIO-RESPIRATORY ARREST 864 0.0206
147 TOOTH ABSCESS 210 0.0206
148 SINUS CONGESTION 278 0.0206
149 TENDERNESS 214 0.0205
150 DUODENAL ULCER PERFORATION 152 0.0204
151 SKIN LACERATION 218 0.0200
152 ANIMAL BITE 53 0.0199
153 MONOCYTE COUNT INCREASED 72 0.0198
154 PRODUCT DISTRIBUTION ISSUE 183 0.0197
155 CENTRAL VENOUS CATHETERISATION 59 0.0195
156 RHINOVIRUS INFECTION 76 0.0195
157 COVID-19 PNEUMONIA 230 0.0195
158 RHEUMATOID FACTOR POSITIVE 112 0.0194
159 MENINGITIS ASEPTIC 87 0.0194
160 SINUS DISORDER 380 0.0192
161 HYPERCHOLESTEROLAEMIA 182 0.0188
162 DRUG LEVEL DECREASED 191 0.0187
163 GASTROINTESTINAL INFECTION 168 0.0187
164 BLOOD PRESSURE INCREASED 2827 0.0185
165 PULSELESS ELECTRICAL ACTIVITY 77 0.0184
166 HORDEOLUM 79 0.0182
167 BLOOD PRESSURE SYSTOLIC DECREASED 83 0.0182
168 STREPTOCOCCAL INFECTION 101 0.0181
169 CYSTITIS 571 0.0179
170 RESPIRATORY ARREST 494 0.0179
171 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3218 0.0178
172 EXOSTOSIS 162 0.0177
173 HEART RATE ABNORMAL 97 0.0174
174 SERUM SICKNESS 48 0.0172
175 RESPIRATORY DEPRESSION 211 0.0172
176 POISONING 216 0.0172
177 PARANASAL SINUS DISCOMFORT 65 0.0172
178 ATYPICAL PNEUMONIA 51 0.0170
179 HYPERREFLEXIA 59 0.0169
180 JOINT DISLOCATION 179 0.0169
181 PROTEIN URINE PRESENT 84 0.0168
182 CLONUS 46 0.0168
183 ARTHROPOD BITE 124 0.0167
184 PHARYNGEAL SWELLING 163 0.0166
185 ORAL INFECTION 65 0.0166
186 VIRAL INFECTION 552 0.0166
187 HAND DEFORMITY 217 0.0165
188 VAGINAL DISCHARGE 166 0.0164
189 FOLLICULITIS 172 0.0164
190 GRIP STRENGTH DECREASED 143 0.0162
191 FOOT DEFORMITY 180 0.0162
192 FOOD POISONING 85 0.0159
193 CONTRAINDICATED PRODUCT ADMINISTERED 478 0.0158
194 BREAST CANCER STAGE III 102 0.0157
195 VAGINAL INFECTION 74 0.0157
196 BLOOD CREATININE DECREASED 49 0.0156
197 URINE ABNORMALITY 71 0.0156
198 MUSCLE INJURY 129 0.0156
199 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 92 0.0155
200 VASCULAR DEVICE INFECTION 70 0.0154
201 OROPHARYNGEAL DISCOMFORT 139 0.0154
202 RASH ERYTHEMATOUS 735 0.0154
203 PULSE ABSENT 73 0.0153
204 LYME DISEASE 51 0.0153
205 BRONCHIECTASIS 103 0.0153
206 RESPIRATORY RATE DECREASED 48 0.0153
207 KIDNEY INFECTION 299 0.0152
208 PRODUCTIVE COUGH 725 0.0152
209 LOCALISED INFECTION 367 0.0152
210 VASCULITIS 176 0.0151
211 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 98 0.0151
212 COVID-19 2621 0.0149
213 RHINITIS 120 0.0149
214 NASOPHARYNGITIS 2718 0.0147
215 THROAT TIGHTNESS 395 0.0146
216 BACTERAEMIA 173 0.0146
217 RESPIRATORY TRACT CONGESTION 231 0.0145
218 PEMPHIGUS 180 0.0144
219 RESPIRATORY SYNCYTIAL VIRUS INFECTION 125 0.0143
220 SYNOVITIS 251 0.0139
221 POST PROCEDURAL INFECTION 113 0.0139
222 THERAPEUTIC RESPONSE SHORTENED 451 0.0136
223 SCIATICA 215 0.0135
224 INFLUENZA 1503 0.0135
225 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 69 0.0134
226 ARTERIOSPASM CORONARY 54 0.0134
227 LUPUS-LIKE SYNDROME 122 0.0134
228 RHEUMATOID ARTHRITIS 1523 0.0134
229 HEART RATE INCREASED 1317 0.0133
230 C-REACTIVE PROTEIN INCREASED 481 0.0132
231 OROPHARYNGEAL PAIN 1222 0.0132
232 VEIN DISORDER 66 0.0132
233 EAR PAIN 255 0.0131
234 NASAL CONGESTION 770 0.0131
235 FREQUENT BOWEL MOVEMENTS 352 0.0130
236 LOWER RESPIRATORY TRACT INFECTION 590 0.0130
237 UNRESPONSIVE TO STIMULI 332 0.0129
238 LIMB INJURY 349 0.0128
239 LIGAMENT SPRAIN 127 0.0128
240 CANDIDA INFECTION 216 0.0128
241 HEPATIC ENZYME INCREASED 867 0.0127
242 FIBROMYALGIA 309 0.0127
243 CHEST DISCOMFORT 1299 0.0127
244 EAR DISORDER 58 0.0127
245 FISTULA 142 0.0126
246 MYDRIASIS 162 0.0126
247 GINGIVITIS 68 0.0126
248 POSTOPERATIVE WOUND INFECTION 85 0.0126
249 FUNGAL INFECTION 419 0.0126
250 NERVE COMPRESSION 116 0.0126
251 WOUND 351 0.0125
252 CLOSTRIDIUM DIFFICILE INFECTION 274 0.0125
253 INFECTION 1811 0.0125
254 DELIRIUM 433 0.0125
255 URINARY TRACT INFECTION 2110 0.0124
256 ANAL FISTULA 66 0.0124
257 TORSADE DE POINTES 97 0.0124
258 LIP DRY 112 0.0123
259 ARTHRITIS INFECTIVE 57 0.0123
260 END STAGE RENAL DISEASE 224 0.0123
261 HYPERTENSION 2598 0.0123
262 PSEUDOMONAS INFECTION 105 0.0122
263 INTENTIONAL DRUG MISUSE 252 0.0120
264 SENSORY LOSS 97 0.0120
265 FLUSHING 1213 0.0119
266 CHILLS 1396 0.0119
267 RHINITIS ALLERGIC 53 0.0119
268 COLITIS 450 0.0119
269 JOINT RANGE OF MOTION DECREASED 159 0.0118
270 SINUS TACHYCARDIA 168 0.0118
271 CONCUSSION 91 0.0117
272 ILLNESS 1209 0.0117
273 PERICARDITIS 197 0.0117
274 TACHYPNOEA 159 0.0117
275 PNEUMONIA BACTERIAL 107 0.0116
276 UVEITIS 158 0.0116
277 RHINORRHOEA 750 0.0116
278 HERPES ZOSTER 664 0.0115
279 BACTERIAL INFECTION 215 0.0115
280 ANAPHYLACTIC REACTION 636 0.0115
281 FLUID RETENTION 584 0.0115
282 DEMYELINATION 47 0.0115
283 NEUTROPHIL COUNT INCREASED 117 0.0114
284 OBESITY 182 0.0114
285 VIRAL UPPER RESPIRATORY TRACT INFECTION 54 0.0113
286 ATRIOVENTRICULAR BLOCK COMPLETE 76 0.0113
287 HYPOXIA 399 0.0113
288 ARTERIAL OCCLUSIVE DISEASE 89 0.0113
289 HYPOALBUMINAEMIA 88 0.0113
290 GANGRENE 68 0.0113
291 CARDIAC ARREST 931 0.0113
292 LYMPHOCYTE COUNT DECREASED 199 0.0112
293 RALES 65 0.0112
294 SPUTUM DISCOLOURED 106 0.0112
295 MOUTH ULCERATION 234 0.0111
296 SARS-COV-2 TEST POSITIVE 146 0.0110
297 FEELING HOT 677 0.0110
298 FINGER DEFORMITY 53 0.0109
299 HAND FRACTURE 77 0.0109
300 RESPIRATORY DISORDER 325 0.0109
301 PULMONARY CONGESTION 143 0.0108
302 ABSCESS 173 0.0108
303 PULMONARY FIBROSIS 207 0.0108
304 TACHYCARDIA 958 0.0108
305 LOWER LIMB FRACTURE 207 0.0108
306 CELLULITIS 542 0.0107
307 CLOSTRIDIUM DIFFICILE COLITIS 114 0.0107
308 SKIN WARM 62 0.0106
309 DENTAL CARIES 117 0.0106
310 DIVERTICULITIS 293 0.0106
311 NASAL POLYPS 52 0.0105
312 PHLEBITIS 54 0.0105
313 BLOOD IRON DECREASED 125 0.0105
314 SARCOIDOSIS 50 0.0105
315 EXPOSURE DURING PREGNANCY 650 0.0104
316 SUBSTANCE ABUSE 85 0.0104
317 SENSITIVE SKIN 77 0.0104
318 COUGH 2926 0.0104
319 PYREXIA 3599 0.0104
320 DEVICE RELATED INFECTION 160 0.0104
321 BLOOD PRESSURE ABNORMAL 206 0.0104
322 URTICARIA 1733 0.0103
323 BREATH SOUNDS ABNORMAL 51 0.0103
324 ORAL HERPES 201 0.0103
325 ASTHMA 1156 0.0102
326 ORTHOSTATIC HYPOTENSION 178 0.0102
327 ANAL ABSCESS 55 0.0102
328 BLOOD MAGNESIUM DECREASED 88 0.0102
329 SYMPTOM RECURRENCE 61 0.0102
330 FEELING COLD 283 0.0102
331 POST-TRAUMATIC STRESS DISORDER 68 0.0101
332 BRAIN OEDEMA 128 0.0101
333 EAR DISCOMFORT 104 0.0101
334 PNEUMONIA 3277 0.0101
335 MUCOUS STOOLS 50 0.0101
336 MIGRAINE 960 0.0100
337 JOINT SWELLING 1190 0.0098
338 FOOT FRACTURE 186 0.0098
339 TOOTH FRACTURE 108 0.0098
340 SNEEZING 219 0.0098
341 IMPAIRED HEALING 320 0.0097
342 NEPHROPATHY 91 0.0097
343 VITAMIN D DEFICIENCY 95 0.0097
344 CATATONIA 51 0.0097
345 LUNG DISORDER 476 0.0097
346 ERYTHEMA 1989 0.0097
347 INJECTION SITE EXTRAVASATION 119 0.0096
348 HYPOPHOSPHATAEMIA 71 0.0096
349 OFF LABEL USE 8410 0.0096
350 SMALL INTESTINAL OBSTRUCTION 117 0.0095
351 FLANK PAIN 89 0.0095
352 IRRITABLE BOWEL SYNDROME 203 0.0095
353 ARTHRITIS 741 0.0094
354 PROCEDURAL PAIN 261 0.0094
355 WEIGHT INCREASED 2104 0.0094
356 SEROTONIN SYNDROME 180 0.0094
357 HEPATIC CIRRHOSIS 176 0.0094
358 RECTAL HAEMORRHAGE 402 0.0093
359 BLOOD URINE PRESENT 177 0.0093
360 WEIGHT DECREASED 2590 0.0093
361 DECREASED IMMUNE RESPONSIVENESS 91 0.0093
362 MENTAL STATUS CHANGES 257 0.0092
363 PRODUCT USE ISSUE 1737 0.0092
364 WHEEZING 548 0.0092
365 STAPHYLOCOCCAL INFECTION 304 0.0092
366 HERNIA 178 0.0092
367 HYPERSENSITIVITY 1702 0.0092
368 DRY THROAT 93 0.0091
369 RESPIRATORY DISTRESS 252 0.0091
370 RENAL TUBULAR NECROSIS 89 0.0091
371 OSTEOPOROSIS 373 0.0091
372 TRANSFUSION 95 0.0091
373 MUSCLE SPASTICITY 111 0.0090
374 JOINT STIFFNESS 236 0.0090
375 WHITE BLOOD CELL COUNT INCREASED 345 0.0090
376 IRON DEFICIENCY ANAEMIA 83 0.0090
377 ADRENAL INSUFFICIENCY 109 0.0090
378 HYPOGAMMAGLOBULINAEMIA 59 0.0090
379 TUMOUR LYSIS SYNDROME 79 0.0090
380 BLOOD PRESSURE DECREASED 596 0.0090
381 CONDITION AGGRAVATED 2719 0.0089
382 TOOTH DISORDER 198 0.0089
383 COLITIS ULCERATIVE 396 0.0089
384 SCRATCH 93 0.0088
385 INTENTIONAL OVERDOSE 564 0.0088
386 MYASTHENIA GRAVIS 71 0.0088
387 SYSTEMIC LUPUS ERYTHEMATOSUS 312 0.0088
388 PALLOR 239 0.0088
389 HYPERTHERMIA 67 0.0088
390 PROCTALGIA 56 0.0087
391 INTENTIONAL PRODUCT MISUSE 761 0.0087
392 PSYCHOLOGICAL TRAUMA 75 0.0087
393 ELECTROCARDIOGRAM QT PROLONGED 312 0.0087
394 MUSCLE STRAIN 75 0.0087
395 MOUTH SWELLING 50 0.0087
396 TOOTHACHE 156 0.0086
397 HEADACHE 5395 0.0086
398 PULMONARY OEDEMA 385 0.0086
399 BACK PAIN 1997 0.0086
400 PLEURISY 51 0.0086
401 SINUS HEADACHE 51 0.0086
402 NEURALGIA 208 0.0085
403 MOTOR DYSFUNCTION 87 0.0085
404 SKIN PLAQUE 72 0.0085
405 WRIST FRACTURE 102 0.0085
406 CARPAL TUNNEL SYNDROME 119 0.0085
407 GLOSSODYNIA 190 0.0085
408 HAEMATOCHEZIA 468 0.0085
409 OSTEOARTHRITIS 359 0.0085
410 CONTUSION 814 0.0084
411 EATING DISORDER 180 0.0084
412 AFFECT LABILITY 81 0.0084
413 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 439 0.0084
414 LUNG INFECTION 130 0.0084
415 HYPERHIDROSIS 1067 0.0083
416 HYPOTENSION 1660 0.0083
417 LIVE BIRTH 69 0.0082
418 FACIAL PARALYSIS 70 0.0082
419 TREATMENT FAILURE 675 0.0081
420 JOINT INJURY 174 0.0081
421 RIB FRACTURE 167 0.0081
422 LARYNGEAL OEDEMA 50 0.0081
423 NEPHROLITHIASIS 372 0.0081
424 PULMONARY THROMBOSIS 88 0.0081
425 CYST 100 0.0080
426 DRUG INTOLERANCE 777 0.0080
427 THERMAL BURN 57 0.0080
428 DECUBITUS ULCER 65 0.0080
429 INFLUENZA LIKE ILLNESS 655 0.0079
430 PRURITUS 3055 0.0079
431 SCAR 136 0.0079
432 HEMIPLEGIA 66 0.0079
433 SWELLING 742 0.0079
434 CONJUNCTIVITIS 147 0.0079
435 SPINAL DISORDER 75 0.0079
436 LIVER INJURY 194 0.0079
437 ESCHERICHIA INFECTION 65 0.0079
438 DISCOMFORT 482 0.0079
439 ATELECTASIS 76 0.0079
440 MIOSIS 63 0.0078
441 CATARACT 467 0.0078
442 ROAD TRAFFIC ACCIDENT 328 0.0078
443 PRODUCT DOSE OMISSION ISSUE 2296 0.0078
444 MUSCULOSKELETAL STIFFNESS 683 0.0078
445 MENINGITIS 52 0.0078
446 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 64 0.0078
447 GASTROENTERITIS 113 0.0077
448 ARTHROPATHY 430 0.0077
449 ULCER 123 0.0077
450 PNEUMOTHORAX 122 0.0077
451 GASTROINTESTINAL DISORDER 688 0.0077
452 GASTROINTESTINAL INFLAMMATION 60 0.0077
453 UPPER-AIRWAY COUGH SYNDROME 63 0.0076
454 PERIPHERAL SWELLING 1177 0.0076
455 LYMPHOPENIA 108 0.0076
456 HIP ARTHROPLASTY 116 0.0076
457 CARDIOMEGALY 93 0.0076
458 HEMIPARESIS 128 0.0075
459 MYOCLONUS 90 0.0075
460 RESTLESS LEGS SYNDROME 137 0.0075
461 MUCOSAL INFLAMMATION 197 0.0075
462 LIP SWELLING 250 0.0075
463 ARTHRALGIA 3110 0.0075
464 ANGIOEDEMA 329 0.0074
465 MUSCULOSKELETAL DISCOMFORT 128 0.0074
466 NIGHT SWEATS 239 0.0074
467 DRUG TOXICITY 101 0.0074
468 TYPE 2 DIABETES MELLITUS 249 0.0074
469 OEDEMA 401 0.0074
470 PRODUCT PRESCRIBING ERROR 176 0.0074
471 VENTRICULAR TACHYCARDIA 122 0.0074
472 SLEEP APNOEA SYNDROME 141 0.0074
473 SENSATION OF FOREIGN BODY 62 0.0073
474 STOMATITIS 445 0.0073
475 COORDINATION ABNORMAL 102 0.0073
476 ASPIRATION 80 0.0073
477 ACUTE RESPIRATORY DISTRESS SYNDROME 129 0.0073
478 SEIZURE 841 0.0073
479 DEFAECATION URGENCY 51 0.0073
480 POST PROCEDURAL COMPLICATION 139 0.0072
481 ORAL PAIN 162 0.0072
482 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 514 0.0072
483 DYSPHAGIA 684 0.0072
484 ACCIDENTAL OVERDOSE 263 0.0072
485 SKIN MASS 48 0.0072
486 CYANOSIS 113 0.0072
487 PULMONARY MASS 107 0.0072
488 PSYCHOTIC DISORDER 212 0.0072
489 DIVERTICULUM 51 0.0072
490 RETCHING 153 0.0072
491 ACUTE RESPIRATORY FAILURE 138 0.0072
492 HAIR DISORDER 59 0.0072
493 MASS 100 0.0071
494 BLADDER DISORDER 71 0.0071
495 ELECTROLYTE IMBALANCE 83 0.0071
496 INTERVERTEBRAL DISC DEGENERATION 66 0.0071
497 DRUG LEVEL INCREASED 118 0.0071
498 NODULE 93 0.0071
499 MUSCULOSKELETAL CHEST PAIN 110 0.0071
500 NECK PAIN 397 0.0071
501 BACK INJURY 77 0.0071
502 TEMPERATURE INTOLERANCE 73 0.0071
503 FEAR OF INJECTION 50 0.0070
504 FACE OEDEMA 118 0.0070
505 PNEUMONIA ASPIRATION 174 0.0070
506 HEAD INJURY 220 0.0069
507 IMMUNOSUPPRESSION 61 0.0069
508 BLOOD CHOLESTEROL INCREASED 322 0.0069
509 PREGNANCY 138 0.0069
510 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 117 0.0069
511 LYMPHADENOPATHY 243 0.0069
512 BLISTER 385 0.0068
513 PRODUCT AVAILABILITY ISSUE 156 0.0068
514 METABOLIC ACIDOSIS 219 0.0068
515 FATIGUE 5329 0.0068
516 PAIN 4190 0.0068
517 MUSCULAR WEAKNESS 775 0.0068
518 CARDIAC MURMUR 59 0.0068
519 COLD SWEAT 120 0.0068
520 THROMBOCYTOPENIA 760 0.0068
521 ENCEPHALITIS 47 0.0068
522 CHEST PAIN 1258 0.0068
523 ACCIDENT 81 0.0068
524 HAEMORRHOIDS 132 0.0068
525 CEREBRAL DISORDER 50 0.0068
526 SEPSIS 753 0.0067
527 MALAISE 2958 0.0067
528 BRONCHOSPASM 96 0.0067
529 INFLAMMATION 347 0.0067
530 ABDOMINAL PAIN 1559 0.0067
531 HYPOAESTHESIA 998 0.0067
532 HEAD DISCOMFORT 118 0.0067
533 SCAB 76 0.0067
534 OVERDOSE 1435 0.0066
535 INABILITY TO AFFORD MEDICATION 66 0.0066
536 ENCEPHALOPATHY 163 0.0066
537 BRAIN FOG 104 0.0066
538 SECRETION DISCHARGE 83 0.0066
539 CHRONIC KIDNEY DISEASE 500 0.0066
540 UPPER LIMB FRACTURE 131 0.0066
541 OSTEOMYELITIS 119 0.0066
542 KNEE ARTHROPLASTY 138 0.0065
543 PELVIC FRACTURE 51 0.0065
544 GINGIVAL PAIN 52 0.0065
545 GENERALISED TONIC-CLONIC SEIZURE 108 0.0065
546 PETECHIAE 68 0.0065
547 DYSPEPSIA 640 0.0065
548 LIMB DISCOMFORT 201 0.0065
549 PNEUMONITIS 176 0.0065
550 POOR QUALITY SLEEP 138 0.0064
551 LEUKOCYTOSIS 116 0.0064
552 RASH PRURITIC 347 0.0064
553 DEVICE OCCLUSION 90 0.0064
554 HYPOAESTHESIA ORAL 96 0.0064
555 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 109 0.0064
556 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 305 0.0063
557 PYELONEPHRITIS 55 0.0063
558 MOBILITY DECREASED 456 0.0063
559 EMPHYSEMA 64 0.0063
560 SKIN HAEMORRHAGE 94 0.0063
561 LUNG INFILTRATION 56 0.0063
562 MUSCLE TWITCHING 146 0.0063
563 DYSPNOEA 3582 0.0063
564 FRUSTRATION TOLERANCE DECREASED 51 0.0063
565 FURUNCLE 50 0.0063
566 SALIVARY HYPERSECRETION 63 0.0063
567 BRADYCARDIA 334 0.0063
568 RED BLOOD CELL COUNT DECREASED 180 0.0063
569 URINARY RETENTION 210 0.0063
570 MYOCARDITIS 72 0.0063
571 ACIDOSIS 48 0.0063
572 RENAL PAIN 66 0.0062
573 SOMNOLENCE 1250 0.0062
574 URINE OUTPUT DECREASED 54 0.0062
575 PHOTOSENSITIVITY REACTION 102 0.0062
576 AGITATION 453 0.0062
577 HAEMATOCRIT DECREASED 122 0.0061
578 RASH 2681 0.0061
579 DYSARTHRIA 231 0.0061
580 SHOCK 141 0.0061
581 HAEMOGLOBIN DECREASED 629 0.0061
582 ELECTROCARDIOGRAM ABNORMAL 48 0.0061
583 PERIPHERAL COLDNESS 84 0.0061
584 MADAROSIS 71 0.0061
585 HEPATOMEGALY 60 0.0061
586 VITAMIN D DECREASED 52 0.0061
587 BACK DISORDER 98 0.0060
588 FALL 2000 0.0060
589 NAUSEA 4743 0.0060
590 BRAIN INJURY 60 0.0060
591 HIP FRACTURE 192 0.0060
592 APHASIA 180 0.0060
593 ILEUS 74 0.0059
594 OPTIC NEURITIS 54 0.0059
595 ILL-DEFINED DISORDER 361 0.0059
596 NERVE INJURY 66 0.0059
597 OSTEOPENIA 90 0.0059
598 IMMUNE SYSTEM DISORDER 78 0.0059
599 SINUS BRADYCARDIA 57 0.0059
600 DEHYDRATION 786 0.0059
601 TRANSPLANT REJECTION 47 0.0059
602 NEUTROPHIL COUNT DECREASED 238 0.0058
603 THERAPEUTIC PRODUCT EFFECT DECREASED 261 0.0058
604 PAIN IN EXTREMITY 1713 0.0058
605 RASH MACULAR 203 0.0058
606 APHONIA 81 0.0058
607 CYTOPENIA 71 0.0058
608 LEUKOPENIA 289 0.0058
609 CONSTIPATION 1260 0.0058
610 INCONTINENCE 61 0.0058
611 ATRIAL FLUTTER 46 0.0058
612 MUSCULOSKELETAL PAIN 302 0.0058
613 INTENTIONAL DOSE OMISSION 164 0.0057
614 SKIN REACTION 81 0.0057
615 HYPERAESTHESIA 47 0.0057
616 SPINAL OSTEOARTHRITIS 50 0.0057
617 GASTROOESOPHAGEAL REFLUX DISEASE 458 0.0057
618 ANXIETY 1611 0.0057
619 DYSPNOEA EXERTIONAL 213 0.0056
620 THERAPY NON-RESPONDER 254 0.0056
621 MATERNAL EXPOSURE DURING PREGNANCY 503 0.0056
622 PRESYNCOPE 137 0.0056
623 IMPAIRED QUALITY OF LIFE 81 0.0056
624 SPINAL PAIN 66 0.0056
625 TOOTH EXTRACTION 70 0.0056
626 MICTURITION URGENCY 64 0.0056
627 VOMITING 2634 0.0056
628 LETHARGY 321 0.0056
629 SKIN CANCER 120 0.0056
630 HAIR COLOUR CHANGES 69 0.0055
631 INTERVERTEBRAL DISC PROTRUSION 121 0.0055
632 ANKLE FRACTURE 85 0.0055
633 PLEURAL EFFUSION 334 0.0055
634 SWOLLEN TONGUE 171 0.0055
635 SKIN LESION 150 0.0055
636 OEDEMA PERIPHERAL 666 0.0055
637 GOUT 98 0.0055
638 HYPOKALAEMIA 252 0.0055
639 HAIR TEXTURE ABNORMAL 73 0.0055
640 BASAL CELL CARCINOMA 85 0.0054
641 SPINAL OPERATION 67 0.0054
642 HYPOTHERMIA 55 0.0054
643 IMPAIRED GASTRIC EMPTYING 74 0.0054
644 ABDOMINAL DISTENSION 566 0.0054
645 UROSEPSIS 50 0.0054
646 ARTERIOSCLEROSIS 51 0.0054
647 PROTEINURIA 103 0.0054
648 HIATUS HERNIA 70 0.0054
649 BURNING SENSATION 378 0.0054
650 DEPRESSED LEVEL OF CONSCIOUSNESS 213 0.0054
651 FACIAL PAIN 48 0.0054
652 NAIL DISORDER 47 0.0054
653 PANCREATITIS 281 0.0053
654 GAIT INABILITY 177 0.0053
655 PRODUCT ADMINISTRATION ERROR 107 0.0053
656 ALANINE AMINOTRANSFERASE INCREASED 325 0.0053
657 BLOOD POTASSIUM DECREASED 159 0.0053
658 PAIN IN JAW 149 0.0053
659 COMPLICATION ASSOCIATED WITH DEVICE 76 0.0052
660 BLOOD BILIRUBIN INCREASED 141 0.0052
661 PARAESTHESIA 819 0.0052
662 URINARY INCONTINENCE 154 0.0052
663 MUSCLE RIGIDITY 62 0.0052
664 ABDOMINAL DISCOMFORT 868 0.0052
665 RESTLESSNESS 189 0.0052
666 GALLBLADDER DISORDER 91 0.0051
667 ATRIAL FIBRILLATION 493 0.0051
668 CHOLELITHIASIS 166 0.0051
669 ROTATOR CUFF SYNDROME 65 0.0051
670 RESPIRATORY FAILURE 369 0.0051
671 PALPITATIONS 592 0.0050
672 BODY HEIGHT DECREASED 54 0.0050
673 ANAEMIA 960 0.0050
674 HEPATOTOXICITY 112 0.0050
675 DYSURIA 185 0.0050
676 ANGINA PECTORIS 144 0.0050
677 CARDIOGENIC SHOCK 72 0.0050
678 BLOOD UREA INCREASED 84 0.0050
679 BLOOD THYROID STIMULATING HORMONE INCREASED 46 0.0050
680 ASTHENIA 1878 0.0050
681 INTESTINAL PERFORATION 56 0.0050
682 HAEMOPTYSIS 139 0.0050
683 PRODUCT USE IN UNAPPROVED INDICATION 1235 0.0050
684 HOT FLUSH 375 0.0050
685 NEUROTOXICITY 87 0.0050
686 LACRIMATION INCREASED 150 0.0050
687 ANAPHYLACTIC SHOCK 128 0.0050
688 LIVER FUNCTION TEST INCREASED 106 0.0049
689 HYPERBILIRUBINAEMIA 51 0.0049
690 THROMBOSIS 396 0.0049
691 COAGULOPATHY 82 0.0049
692 NEEDLE ISSUE 143 0.0049
693 HYPERGLYCAEMIA 179 0.0049
694 OVARIAN CYST 49 0.0049
695 SWELLING FACE 316 0.0048
696 HYPERSOMNIA 139 0.0048
697 INCORRECT PRODUCT ADMINISTRATION DURATION 105 0.0048
698 LABORATORY TEST ABNORMAL 143 0.0048
699 PERICARDIAL EFFUSION 112 0.0048
700 SPINAL FRACTURE 97 0.0048
701 FEEDING DISORDER 98 0.0048
702 DRY MOUTH 392 0.0048
703 DISSEMINATED INTRAVASCULAR COAGULATION 68 0.0048
704 DIZZINESS 2401 0.0048
705 BLOOD CREATININE INCREASED 314 0.0048
706 EPISTAXIS 359 0.0048
707 SKIN DISCOLOURATION 220 0.0048
708 HYPERCALCAEMIA 59 0.0048
709 HEPATIC STEATOSIS 89 0.0048
710 BLOOD ALKALINE PHOSPHATASE INCREASED 118 0.0047
711 WHITE BLOOD CELL COUNT DECREASED 515 0.0047
712 LIVER FUNCTION TEST ABNORMAL 138 0.0047
713 MALNUTRITION 53 0.0047
714 DYSPHONIA 277 0.0047
715 ACUTE KIDNEY INJURY 724 0.0047
716 BLOOD SODIUM DECREASED 89 0.0047
717 GAIT DISTURBANCE 899 0.0047
718 CONFUSIONAL STATE 759 0.0047
719 ECONOMIC PROBLEM 71 0.0047
720 EYE DISORDER 154 0.0047
721 GASTRIC ULCER 89 0.0047
722 THYROID DISORDER 72 0.0047
723 ABDOMINAL PAIN UPPER 960 0.0047
724 SEDATION 122 0.0047
725 NERVOUSNESS 243 0.0046
726 ACUTE MYOCARDIAL INFARCTION 137 0.0046
727 TREMOR 770 0.0046
728 VENTRICULAR EXTRASYSTOLES 48 0.0046
729 GENERALISED OEDEMA 57 0.0046
730 ASPARTATE AMINOTRANSFERASE INCREASED 244 0.0046
731 INTESTINAL OBSTRUCTION 173 0.0046
732 NEUROPATHY PERIPHERAL 436 0.0046
733 DIPLOPIA 119 0.0046
734 LOSS OF CONSCIOUSNESS 584 0.0046
735 BLOOD TEST ABNORMAL 64 0.0046
736 INTERNAL HAEMORRHAGE 52 0.0045
737 COMA 216 0.0045
738 SLEEP DISORDER 320 0.0045
739 DERMATITIS 95 0.0045
740 SEPTIC SHOCK 197 0.0045
741 BONE PAIN 265 0.0045
742 MULTIPLE ORGAN DYSFUNCTION SYNDROME 128 0.0045
743 MUSCLE TIGHTNESS 73 0.0045
744 MUSCLE SPASMS 825 0.0045
745 TASTE DISORDER 91 0.0045
746 GASTRITIS 118 0.0045
747 MYOCARDIAL ISCHAEMIA 51 0.0045
748 RENAL FAILURE 590 0.0044
749 SKIN DISORDER 148 0.0044
750 NEOPLASM 51 0.0044
751 EYE DISCHARGE 46 0.0044
752 PHOTOPHOBIA 83 0.0044
753 FLUID OVERLOAD 64 0.0044
754 PLATELET COUNT DECREASED 468 0.0044
755 LIVER DISORDER 194 0.0044
756 GASTROINTESTINAL PAIN 48 0.0044
757 SYNCOPE 432 0.0043
758 PRESCRIBED UNDERDOSE 86 0.0043
759 INSOMNIA 1148 0.0043
760 DECREASED APPETITE 1001 0.0043
761 MIDDLE INSOMNIA 80 0.0043
762 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 235 0.0043
763 DRUG INTERACTION 679 0.0043
764 EYE SWELLING 159 0.0043
765 BLOOD CALCIUM DECREASED 48 0.0043
766 PANCYTOPENIA 237 0.0042
767 HYPOMAGNESAEMIA 59 0.0042
768 HYPONATRAEMIA 238 0.0042
769 INJURY 295 0.0042
770 OCULAR DISCOMFORT 47 0.0042
771 ARRHYTHMIA 198 0.0042
772 DIABETES MELLITUS INADEQUATE CONTROL 74 0.0042
773 SKIN ULCER 108 0.0042
774 ACUTE HEPATIC FAILURE 57 0.0042
775 ABDOMINAL PAIN LOWER 105 0.0041
776 ANHEDONIA 109 0.0041
777 DIARRHOEA 2676 0.0041
778 GASTRIC DISORDER 142 0.0041
779 GENERAL PHYSICAL HEALTH DETERIORATION 477 0.0041
780 AMNESIA 268 0.0041
781 BALANCE DISORDER 356 0.0041
782 VERTIGO 251 0.0041
783 ASCITES 119 0.0040
784 ALOPECIA 785 0.0040
785 CARDIOMYOPATHY 59 0.0040
786 PLATELET COUNT INCREASED 52 0.0040
787 BLOOD LACTATE DEHYDROGENASE INCREASED 63 0.0040
788 RENAL INJURY 118 0.0040
789 SCHIZOPHRENIA 48 0.0039
790 HYPOTHYROIDISM 126 0.0039
791 HYPERLIPIDAEMIA 47 0.0039
792 EYE PRURITUS 132 0.0039
793 MYALGIA 667 0.0039
794 TRANSIENT ISCHAEMIC ATTACK 132 0.0039
795 CARDIAC DISORDER 366 0.0039
796 HAEMATOMA 101 0.0039
797 PARALYSIS 55 0.0038
798 RASH PAPULAR 86 0.0038
799 RASH MACULO-PAPULAR 85 0.0038
800 CHOKING 74 0.0038
801 SUICIDE ATTEMPT 229 0.0038
802 PSORIASIS 493 0.0038
803 HYPOGLYCAEMIA 183 0.0038
804 FULL BLOOD COUNT DECREASED 76 0.0038
805 MOVEMENT DISORDER 120 0.0037
806 HYPERKALAEMIA 131 0.0037
807 FEELING JITTERY 71 0.0037
808 FEMUR FRACTURE 115 0.0037
809 POLLAKIURIA 154 0.0037
810 SPEECH DISORDER 193 0.0037
811 PSYCHOMOTOR HYPERACTIVITY 61 0.0037
812 PSORIATIC ARTHROPATHY 149 0.0037
813 FEELING ABNORMAL 877 0.0037
814 DISORIENTATION 145 0.0037
815 RENAL DISORDER 170 0.0036
816 TUBULOINTERSTITIAL NEPHRITIS 68 0.0036
817 BLOOD TRIGLYCERIDES INCREASED 64 0.0036
818 ADVERSE REACTION 48 0.0036
819 NEUTROPENIA 491 0.0036
820 HYPOPHAGIA 92 0.0036
821 LYMPHOMA 55 0.0036
822 COGNITIVE DISORDER 166 0.0036
823 PRODUCT USE COMPLAINT 56 0.0036
824 OCULAR HYPERAEMIA 168 0.0035
825 PRODUCT DOSE OMISSION IN ERROR 100 0.0035
826 FLATULENCE 198 0.0035
827 TENDONITIS 54 0.0035
828 MUSCULOSKELETAL DISORDER 66 0.0035
829 DRY EYE 173 0.0035
830 DISEASE PROGRESSION 410 0.0035
831 PULMONARY EMBOLISM 328 0.0034
832 PRODUCT PRESCRIBING ISSUE 75 0.0034
833 DRUG-INDUCED LIVER INJURY 108 0.0034
834 PANIC ATTACK 125 0.0034
835 UNDERDOSE 250 0.0034
836 RHABDOMYOLYSIS 142 0.0034
837 BONE DISORDER 62 0.0034
838 DYSSTASIA 99 0.0034
839 HAEMORRHAGE 354 0.0034
840 FRACTURE 64 0.0034
841 TRANSAMINASES INCREASED 75 0.0034
842 AKATHISIA 46 0.0034
843 CENTRAL NERVOUS SYSTEM LESION 46 0.0033
844 HYPOCALCAEMIA 63 0.0033
845 MULTIPLE SCLEROSIS 159 0.0033
846 ECZEMA 173 0.0033
847 HAEMATURIA 113 0.0033
848 INTERNATIONAL NORMALISED RATIO INCREASED 94 0.0033
849 HALLUCINATION 248 0.0033
850 PHARYNGEAL OEDEMA 50 0.0032
851 BONE MARROW FAILURE 66 0.0032
852 DISEASE RECURRENCE 154 0.0032
853 DISABILITY 64 0.0032
854 DEPRESSION 731 0.0032
855 THERAPY PARTIAL RESPONDER 50 0.0032
856 METASTASES TO BONE 52 0.0032
857 MANIA 52 0.0032
858 DELUSION 49 0.0032
859 VISUAL IMPAIRMENT 390 0.0031
860 INCORRECT DOSE ADMINISTERED 716 0.0031
861 TOOTH LOSS 65 0.0031
862 DRUG ERUPTION 55 0.0031
863 CHROMATURIA 70 0.0031
864 DYSTONIA 60 0.0031
865 FAECES DISCOLOURED 67 0.0031
866 DRUG INEFFECTIVE 4064 0.0031
867 ACUTE MYELOID LEUKAEMIA 48 0.0031
868 RENAL IMPAIRMENT 258 0.0031
869 CYTOMEGALOVIRUS INFECTION 51 0.0031
870 EYE PAIN 173 0.0031
871 DEPRESSED MOOD 162 0.0031
872 MEMORY IMPAIRMENT 421 0.0031
873 GLAUCOMA 59 0.0031
874 CRYING 111 0.0031
875 HEPATIC FAILURE 92 0.0030
876 HAEMATEMESIS 77 0.0030
877 GAMMA-GLUTAMYLTRANSFERASE INCREASED 67 0.0030
878 THERAPY INTERRUPTED 216 0.0030
879 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 101 0.0030
880 EJECTION FRACTION DECREASED 46 0.0030
881 BLOOD POTASSIUM INCREASED 48 0.0030
882 INTERSTITIAL LUNG DISEASE 143 0.0030
883 DIABETES MELLITUS 224 0.0029
884 DYSKINESIA 119 0.0029
885 PLASMA CELL MYELOMA 114 0.0029
886 TINNITUS 134 0.0029
887 THIRST 52 0.0029
888 THINKING ABNORMAL 54 0.0029
889 PELVIC PAIN 52 0.0029
890 MENTAL DISORDER 124 0.0028
891 DEEP VEIN THROMBOSIS 185 0.0028
892 VISION BLURRED 389 0.0028
893 UNEVALUABLE EVENT 214 0.0028
894 PRURITUS GENERALISED 61 0.0028
895 TREATMENT NONCOMPLIANCE 154 0.0028
896 HALLUCINATION, VISUAL 59 0.0028
897 DEATH 2396 0.0028
898 SKIN EXFOLIATION 234 0.0028
899 PANCREATITIS ACUTE 62 0.0028
900 BLINDNESS 112 0.0027
901 CARDIAC FAILURE CONGESTIVE 220 0.0027
902 AGGRESSION 135 0.0027
903 HOSPITALISATION 413 0.0027
904 NERVOUS SYSTEM DISORDER 83 0.0027
905 INJECTION SITE SWELLING 202 0.0026
906 ADVERSE DRUG REACTION 236 0.0026
907 CARDIAC FAILURE 210 0.0026
908 MEDICATION ERROR 145 0.0026
909 DEAFNESS 68 0.0026
910 ALTERED STATE OF CONSCIOUSNESS 56 0.0026
911 DEMENTIA 72 0.0026
912 BLOOD CREATINE PHOSPHOKINASE INCREASED 74 0.0026
913 NEOPLASM MALIGNANT 171 0.0026
914 IRRITABILITY 154 0.0026
915 DISTURBANCE IN ATTENTION 138 0.0026
916 RASH GENERALISED 66 0.0025
917 ACNE 192 0.0025
918 LACTIC ACIDOSIS 82 0.0025
919 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 65 0.0025
920 THERAPEUTIC RESPONSE DECREASED 149 0.0025
921 STEVENS-JOHNSON SYNDROME 54 0.0024
922 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 56 0.0024
923 PULMONARY HYPERTENSION 50 0.0024
924 CEREBROVASCULAR ACCIDENT 402 0.0024
925 LUNG NEOPLASM MALIGNANT 97 0.0024
926 IMPAIRED WORK ABILITY 49 0.0023
927 MOOD ALTERED 62 0.0023
928 CEREBRAL HAEMORRHAGE 81 0.0023
929 BLOOD GLUCOSE DECREASED 108 0.0022
930 SURGERY 130 0.0022
931 EXTRAPYRAMIDAL DISORDER 55 0.0022
932 GASTROINTESTINAL HAEMORRHAGE 184 0.0022
933 HEPATIC FUNCTION ABNORMAL 82 0.0022
934 SKIN IRRITATION 100 0.0022
935 HEPATITIS 55 0.0021
936 MENTAL IMPAIRMENT 52 0.0021
937 EMOTIONAL DISORDER 66 0.0021
938 DYSGEUSIA 158 0.0021
939 DIABETIC KETOACIDOSIS 51 0.0021
940 EMOTIONAL DISTRESS 255 0.0021
941 INJECTION SITE REACTION 144 0.0021
942 DRY SKIN 273 0.0020
943 GLYCOSYLATED HAEMOGLOBIN INCREASED 51 0.0020
944 MYELOSUPPRESSION 72 0.0020
945 INJECTION SITE PRURITUS 133 0.0020
946 INJECTION SITE ERYTHEMA 236 0.0019
947 EYE IRRITATION 109 0.0019
948 MYOCARDIAL INFARCTION 330 0.0019
949 AGEUSIA 47 0.0019
950 BREAST CANCER 175 0.0019
951 HYPOACUSIS 80 0.0019
952 FOETAL EXPOSURE DURING PREGNANCY 151 0.0019
953 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 54 0.0018
954 ABNORMAL BEHAVIOUR 72 0.0018
955 NEOPLASM PROGRESSION 63 0.0018
956 DEVICE BREAKAGE 73 0.0018
957 BONE DENSITY DECREASED 56 0.0018
958 MULTIPLE SCLEROSIS RELAPSE 120 0.0017
959 MALIGNANT NEOPLASM PROGRESSION 179 0.0017
960 PAIN OF SKIN 47 0.0017
961 FEAR 46 0.0017
962 SUICIDAL IDEATION 154 0.0017
963 INJECTION SITE MASS 62 0.0017
964 EPILEPSY 51 0.0017
965 ADVERSE EVENT 152 0.0016
966 NIGHTMARE 57 0.0016
967 OSTEONECROSIS 54 0.0016
968 WITHDRAWAL SYNDROME 69 0.0016
969 DEVICE ISSUE 146 0.0016
970 ANGER 55 0.0016
971 DRUG DEPENDENCE 260 0.0016
972 CORONARY ARTERY DISEASE 46 0.0015
973 BLOOD GLUCOSE INCREASED 286 0.0015
974 NO ADVERSE EVENT 272 0.0015
975 THERAPEUTIC RESPONSE UNEXPECTED 66 0.0015
976 DRUG EFFECT INCOMPLETE 53 0.0015
977 PRODUCT DOSE OMISSION 90 0.0014
978 CONVULSION 77 0.0013
979 ABORTION SPONTANEOUS 53 0.0013
980 DRUG WITHDRAWAL SYNDROME 115 0.0013
981 INJECTION SITE BRUISING 104 0.0013
982 VAGINAL HAEMORRHAGE 56 0.0013
983 INJECTION SITE PAIN 376 0.0012
984 RENAL FAILURE ACUTE 52 0.0012
985 THERAPY CESSATION 60 0.0012
986 INJECTION SITE HAEMORRHAGE 77 0.0010
987 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 61 0.0009
988 DEVICE MALFUNCTION 59 0.0008
989 PRODUCT QUALITY ISSUE 113 0.0008
990 DRUG DOSE OMISSION 133 0.0008
991 SKIN BURNING SENSATION 57 0.0008
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 152 0.0007
993 ACCIDENTAL EXPOSURE TO PRODUCT 72 0.0007
994 PROSTATE CANCER 52 0.0006
995 PRODUCT STORAGE ERROR 54 0.0006